Adjuvant hormonal therapy in premenopausal women with breast cancer.

about

Cognizance and utilization about breast cancer screening among the health professional female students and staffs of University Kuala Lumpur, Royal College of Medicine Perak, Malaysia.

P2860

Q37584937-BD811141-7E21-4A0F-A7C7-64E0120C2E15

P2860

Adjuvant hormonal therapy in premenopausal women with breast cancer.

Item

http://www.wikidata.org/entity/Q36457989

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Adjuvant hormonal therapy in premenopausal women with breast cancer.

@ast

Adjuvant hormonal therapy in premenopausal women with breast cancer.

@en

type

Item

label

Adjuvant hormonal therapy in premenopausal women with breast cancer.

@ast

Adjuvant hormonal therapy in premenopausal women with breast cancer.

@en

prefLabel

Adjuvant hormonal therapy in premenopausal women with breast cancer.

@ast

Adjuvant hormonal therapy in premenopausal women with breast cancer.

@en

P1476

Adjuvant hormonal therapy in premenopausal women with breast cancer.

@en

P2093

Clifford Hudis

http://www.w3.org/2001/XMLSchema#string

Lillian Smyth

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials.

Steroid hormone receptors in breast cancer management.

Ovarian ablation in breast cancer, 1896 to 1998: milestones along hierarchy of evidence from case report to Cochrane review.

Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.

Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole.

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.

P304

195-200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.4103/0971-5851.171530

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26811586

http://www.w3.org/2001/XMLSchema#string

P932

4711215

http://www.w3.org/2001/XMLSchema#string

Adjuvant hormonal therapy in premenopausal women with breast cancer.

about

P2860

P2860

Adjuvant hormonal therapy in premenopausal women with breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932